Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Lancet (London, England)|September 10, 2010
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trialKim-Thanh Ong, Jérôme Perdu, Julie De Backer, et al.Hypertension (Dallas, Tex. : 1979)|February 12, 2025
Modulation of Calcium Signaling on Demand to Decipher the Molecular Mechanisms of Primary AldosteronismBakhta Fedlaoui, Teresa Cosentino, Zeina R Al Sayed, et al.Cardiovascular Research|June 12, 2021
COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the HeartMaurizio Pesce, Piergiuseppe Agostoni, Hans-Erik Bøtker, et al.European Journal of Heart Failure|December 30, 2021
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Rudolf A de Boer, Stephane Heymans, Johannes Backs, et al.Journal of Thrombosis and Thrombolysis|November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.Cardiovascular Research|January 19, 2019
ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failureRosalinda Madonna, Linda W Van Laake, Hans Erik Botker, et al.Nature Communications|April 30, 2015
Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapyIoannis Karakikes, Francesca Stillitano, Mathieu Nonnenmacher, et al.Nature Communications|March 6, 2021
Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodelingIcia Santos-Zas, Jeremie Lemarié, Ivana Zlatanova, et al.Nature Communications|April 1, 2026
NK cells promote cardiac cell death and regulate myelopoiesis in myocardial infarctionRaphael Cohen, Vincent Duval, Rida Al-Rifai, et al.European Journal of Heart Failure|October 2, 2020
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of CardiologyRadek Pudil, Christian Mueller, Jelena Čelutkienė, et al.Pageof 5